全文获取类型
收费全文 | 37602篇 |
免费 | 3939篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 482篇 |
儿科学 | 1117篇 |
妇产科学 | 766篇 |
基础医学 | 5390篇 |
口腔科学 | 1446篇 |
临床医学 | 4284篇 |
内科学 | 7489篇 |
皮肤病学 | 450篇 |
神经病学 | 2953篇 |
特种医学 | 1413篇 |
外国民族医学 | 2篇 |
外科学 | 5012篇 |
综合类 | 955篇 |
一般理论 | 30篇 |
预防医学 | 3921篇 |
眼科学 | 1043篇 |
药学 | 2839篇 |
1篇 | |
中国医学 | 29篇 |
肿瘤学 | 1994篇 |
出版年
2021年 | 535篇 |
2020年 | 342篇 |
2019年 | 558篇 |
2018年 | 643篇 |
2017年 | 488篇 |
2016年 | 509篇 |
2015年 | 631篇 |
2014年 | 878篇 |
2013年 | 1304篇 |
2012年 | 1707篇 |
2011年 | 1782篇 |
2010年 | 1009篇 |
2009年 | 1004篇 |
2008年 | 1567篇 |
2007年 | 1686篇 |
2006年 | 1551篇 |
2005年 | 1600篇 |
2004年 | 1459篇 |
2003年 | 1388篇 |
2002年 | 1369篇 |
2001年 | 1103篇 |
2000年 | 1158篇 |
1999年 | 1087篇 |
1998年 | 475篇 |
1997年 | 393篇 |
1996年 | 450篇 |
1995年 | 391篇 |
1994年 | 400篇 |
1993年 | 364篇 |
1992年 | 867篇 |
1991年 | 856篇 |
1990年 | 873篇 |
1989年 | 800篇 |
1988年 | 756篇 |
1987年 | 757篇 |
1986年 | 713篇 |
1985年 | 725篇 |
1984年 | 536篇 |
1983年 | 491篇 |
1982年 | 320篇 |
1981年 | 328篇 |
1980年 | 300篇 |
1979年 | 474篇 |
1978年 | 382篇 |
1977年 | 310篇 |
1976年 | 294篇 |
1974年 | 374篇 |
1973年 | 362篇 |
1972年 | 297篇 |
1971年 | 311篇 |
排序方式: 共有10000条查询结果,搜索用时 359 毫秒
21.
22.
23.
Megan A. O’Grady Kristina Wilson Jennifer J. Harman 《The journal of primary prevention》2009,30(6):716-731
The purpose of this study was to evaluate a single-session peer-led safer sex intervention, based on the Information-Motivation-Behavioral
Skills theoretical model, for college students residing in campus residence halls. Participants (N = 108) were assigned to either an hour long control or 5-module intervention session. Compared to the control condition,
the intervention increased participants’ information and women’s subjective norms about preventative behavior. Both the control
and intervention sessions increased intentions to perform preventative behaviors (e.g., keep condoms available). These preliminary
results suggest that this intervention is promising for increasing constructs associated with safer sexual behavior and could
easily be implemented by residence hall staff. 相似文献
24.
25.
26.
J. Duteil FA Rambert AM Pointeau P. Mangiameli and E. Assous 《Fundamental & clinical pharmacology》1991,5(8):695-708
The potential antidepressant effect of flerobuterol (dl-(fluoro-2 phenyl)-1 t-butylamino-2 ethanol), a new drug related to beta-adrenoceptor agonists, was evaluated and compared with imipramine and salbutamol using classical psychopharmacological tests in mice. Like imipramine and salbutamol, flerobuterol (0.5-32 mg kg-1, ip) fully prevented apomorphine (16 mg kg-1, sc)- and partly reversed reserpine- and oxotremorine-induced hypothermia. At higher doses (16-32 mg kg-1), flerobuterol enhanced the toxic effects of yohimbine. Unlike imipramine, flerobuterol and salbutamol did not reduce immobility duration in the behavioural despair test. Salbutamol and flerobuterol decreased locomotor activity. Flerobuterol did not induce mydriasis, did not prevent oxotremorine-induced tremors or salivary and lacrimal gland secretion and did not reduce reserpine-induced palpebral ptosis. Propranolol (8 mg kg-1, ip) but not alpha-methyl-paratyrosine (75 mg kg-1, ip) prevented the flerobuterol-induced antagonism of apomorphine-induced hypothermia. Our results suggest that flerobuterol demonstrates potential antidepressant activity, which could be related to beta-adrenoceptor activation in mice. 相似文献
27.
Dr. B. H.Ch. Stricker R. R. M. de Groot J. H. P. Wilson 《European journal of clinical pharmacology》1991,40(4):367-371
Summary In 1981 generalized anaphylaxis was registered on 166 occasions in Dutch general and academic hospitals. Clinical details of 120 of those patients revealed that in 107 anaphylaxis was either probable (n=90) or possible (n=17), whereas in 13 cases some other reaction than anaphylaxis had occurred. The series of confirmed cases contained 46 men and 61 women, with mean ages of 47 y and 48 y, respectively.There was a complete recovery in 102 patients and two patients died. Hypotension was present in 79 cases (74%), dyspnoea in 34 cases (32%) and a skin reaction, mainly urticaria, erythema or angioedema, was mentioned in 62 cases (58%). Most cases of anaphylaxis were drug-induced (76%), the main causes being the analgesic glafenine and contrast media. Glafenine was mentioned as the cause in 36% of all admissions for drug-induced anaphylaxis. Only 3.7% of cases had been reported to the voluntary reporting scheme of the Netherlands Centre for Monitoring of Adverse Reactions to Drugs.On the basis of reimbursement data, the risk of developing severe anaphylaxis to glafenine was estimated at 11.7–19.3-fold relative to indomethacin, and 13.4–20.2-fold relative to oral penicillins. 相似文献
28.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
29.
30.
C4 concentrations and C4 deficiency alleles in systemic lupus erythematosus. 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Annals of the rheumatic diseases》网站下载免费的PDF全文](/ch/ext_images/free.gif)
In a study of 66 patients with systemic lupus erythematosus (SLE) and 80 controls it was found that the presence of two deficiency (null) alleles of C4 had a significant effect on mean C4 concentrations in serum. In six controls who each had two C4 null alleles the mean C4 concentration in serum was 56% lower than in 43 controls without C4 null alleles; the nadir of the C4 concentration in four patients with SLE with two null alleles was also lower by a mean of 55% than in 32 patients who did not have null alleles. Reduced production of C4 allotypes in subjects with two null alleles may be an important determinant of total C4 concentration in patients with SLE. For optimal interpretation of C4 concentrations in SLE, C4 allotyping appears to be indicated, particularly to identify patients who have two null alleles of C4. 相似文献